NEWS
Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)
MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its submission entitled "Lomecel-B inhibition of MMP14 activity predicts Lomecel-B bioactivity in the treatment of mild Alzheimer's disease" has been selected for a late breaking poster presentation at the 17th edition of the Clinical Trials on Alzheimer's Disease Conference (CTAD24) to be held October 29 -November 1, 2024 in Madrid, Spain.
"We are excited to have been selected to present important Lomecel-B™ data at a leading forum for Alzheimer's research and clinical investigation," said Wa'el Hashad, CEO of Longeveron. "We believe the findings offer potential mechanistic and clinical insights in the development of cellular-based therapy for Alzheimer's disease."
Late Breaking Poster Presentation
Date: Tuesday, October 29, 2024, 3:00 p.m. CEST to Wednesday, October 30, 5:00 p.m. CEST
Theme: 11. New Therapies and Clinical Trials
Title: LP029 "Lomecel-B inhibition of MMP14 activity predicts Lomecel-B bioactivity in the treatment of mild Alzheimer's"
"We are excited to have been selected to present important Lomecel-B™ data at a leading forum for Alzheimer's research and clinical investigation," said Wa'el Hashad, CEO of Longeveron. "We believe the findings offer potential mechanistic and clinical insights in the development of cellular-based therapy for Alzheimer's disease."
Late Breaking Poster Presentation
Date: Tuesday, October 29, 2024, 3:00 p.m. CEST to Wednesday, October 30, 5:00 p.m. CEST
Theme: 11. New Therapies and Clinical Trials
Title: LP029 "Lomecel-B inhibition of MMP14 activity predicts Lomecel-B bioactivity in the treatment of mild Alzheimer's"
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment